Joshua Denson, MD: Metabolic Syndrome and COVID-19 Outcomes
Sep 01, 2020, 02:12 PM
In this episode of the endocrine outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of a recent study he led examining the effects of metabolic syndrome on outcomes in patients with coronavirus disease 2019 (COVID-19) in a predominantly Black population.
Results of the study suggest individual components on metabolic syndrome were not associated with worse outcomes but their combined presence in the form of metabolic syndrome resulted in more severe outcomes among their patient population.
In this episode of the endocrine outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of a recent study he led examining the effects of metabolic syndrome on outcomes in patients with coronavirus disease 2019 (COVID-19) in a predominantly Black population.
Results of the study suggest individual components on metabolic syndrome were not associated with worse outcomes but their combined presence in the form of metabolic syndrome resulted in more severe outcomes among their patient population.